{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "650effde",
   "metadata": {},
   "outputs": [],
   "source": [
    "url1 = \"https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-09188-y\"\n",
    "url2 = \"file:///C:/Users/65875/Downloads/s12913-023-09188-y.pdf\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "388c7673",
   "metadata": {},
   "outputs": [],
   "source": [
    "import time\n",
    "from tqdm import tqdm\n",
    "import csv\n",
    "import json\n",
    "import numpy as np\n",
    "import argparse\n",
    "import pandas as pd\n",
    "import requests\n",
    "from bs4 import BeautifulSoup\n",
    "import concurrent.futures\n",
    "from csv import reader\n",
    "import timeout_decorator\n",
    "import datetime\n",
    "from pandas.io.json import json_normalize\n",
    "import nltk\n",
    "import re\n",
    "import datefinder\n",
    "from tqdm import tqdm\n",
    "from urllib.request import urlopen, Request"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b80e0ef6",
   "metadata": {},
   "outputs": [],
   "source": [
    "r = requests.get(url1)\n",
    "soup = BeautifulSoup(r.text, \"html.parser\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "2b39b9d2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Header:  ['Change in glycaemic control with structured diabetes self-management education in urban low-resource settings: multicentre randomised trial of effectiveness']\n",
      "Para:  ['\\nBMC Health Services Research\\nvolume\\xa023, Article\\xa0number:\\xa0199 (2023)\\n            Cite this article\\n']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Abstract']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Background']\n",
      "Para:  ['In high-resource settings, structured diabetes self-management education is associated with improved outcomes but the evidence from low-resource settings is limited and inconclusive.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Aim']\n",
      "Para:  ['To compare, structured diabetes self-management education to usual care, in adults with type 2 diabetes, in low-resource settings.Research design and methods.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Design']\n",
      "Para:  ['Single-blind randomised parallel comparator controlled multi-centre trial.Adults (>\\u200918\\xa0years) with type 2 diabetes from two hospitals in urban Ghana were randomised 1:1 to usual care only, or usual care plus a structured diabetes self-management education program. Randomisation codes were computer-generated, and allotment concealed in opaque numbered envelopes. The intervention effect was assessed with linear mixed models.Main outcome: Change in HbA1c after 3-month follow-up.Primary analysis involved all participants.Clinicaltrial.gov identifier:NCT04780425, retrospectively registered on 03/03/2021.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Results']\n",
      "Para:  ['Recruitment: 22nd until 29th January 2021.We randomised 206 participants (69% female, median age 58\\xa0years [IQR: 49–64], baseline HbA1c median 64\\xa0mmol/mol [IQR: 45–88\\xa0mmol/mol],7.9%[IQR: 6.4–10.2]). Primary outcome data was available for 79 and 80 participants in the intervention and control groups, respectively. Reasons for loss to follow-up were death (n\\u2009=\\u20091), stroke(n\\u2009=\\u20091) and unreachable or unavailable (n\\u2009=\\u200947). A reduction in HbA1c was found in both groups; -9\\xa0mmol/mol [95% CI: -13 to -5\\xa0mmol/mol], -0·9% [95% CI: -1·2% to -0·51%] in the intervention group and -3\\xa0mmol/mol [95% CI -6 to 1\\xa0mmol/mol], -0·3% [95% CI: -0·6% to 0.0%] in the control group. The intervention effect was 1\\xa0mmol/mol [95%CI:-5 TO 8 p\\u2009=\\u20090.726]; 0.1% [95% CI: -0.5, 0.7], p\\u2009=\\u20090·724], adjusted for site, age, and duration of diabetes.No significant harms were observed.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Conclusion']\n",
      "Para:  ['In low-resource settings, diabetes self-management education might not be associated with glycaemic control. Clinician’s expectations from diabetes self-management education must therefore be guarded.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['What is already known on this topic?']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['What this study adds?']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['What are the implications of the study?']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Background']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Methods']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Study design and approval']\n",
      "Para:  ['A multicentre, parallel-group, single-blind randomised controlled trial was conducted at two hospitals (WGMH and KBTH) in Accra, Ghana. Adults living with type 2 diabetes were randomised 1:1 to structured DSME plus usual care, or usual care only.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Ethical approval']\n",
      "Para:  ['Ethical approval was provided by the Ghana Health Service Ethics Review Committee (protocol ID no: GHS-ERC 009/11/20), and the Institutional Review Board of KBTH (protocol ID no: KBTH-IRB 000,175/2021).']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Study participants and study setting']\n",
      "Para:  ['Eligibility criteria included aged 18\\xa0years or above, ability to participate in activities in a group setting, known to have T2DM, and not known to have chronic kidney disease or sickle cell disease.The study was conducted between January-May 2021, at two public primary facilities in Accra, Ghana. Potential participants were identified by searching electronic medical records of the study sites. Using attendance records, trained staff called all potential participants meeting eligibility criteria and invited them to participate. Participants, who expressed interest in the study, were given appointments for a screening visit at the study sites. Participants were recruited from 22nd to 29th January 2021.Prior to any study procedures, all participants gave written informed consent in person. Participants received reimbursement for travel costs and time.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Randomisation and masking']\n",
      "Para:  ['Participants were randomly assigned either to usual care, or usual care plus intervention. Usual care at KBTH polyclinic consisted of informal brief education given by doctors whilst consulting. At WGMH, usual care consisted of unstructured group education, lasting approximately 30\\xa0min, delivered on clinic days; by nurses.Enrolled patients were randomised the same day. Stratified randomisation, by participant age (<\\u200940\\xa0years or\\u2009≥\\u200940\\xa0years), was carried out in variable blocks with the aid of a centralised computer-generated sequence. Each patient randomised had an electronically generated unique identification number matching the assigned study arm. Allotment was concealed in sequentially numbered opaque envelopes and sealed. Care providers at both hospitals were blinded.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Procedures']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Follow-up intervals and assessments']\n",
      "Para:  ['The first 206 patients were consecutively randomised 1:1 either to structured DSME plus usual care or usual care only (Fig.\\xa01). At randomisation (baseline) and three months after randomisation, participants completed an interviewer-administered questionnaire and underwent a clinical assessment. Baseline data was collected on 26th and 27th January 2021 at KBTH, and on 22nd and 29th January 2021 at WGMH. Follow-up data was gathered on 14th and 15th May 2021 at KBTH, and on 20th and 22nd May 2021 at WGMH. The final on-site data collection was conducted at WGMH, on 12th June 2021.Despite prior acceptance of the invitation to participate in endline data collection, some participants failed to show up by the trial end date. Specifically, 71 participants in the intervention group and 78 in the control group completed follow-up at 3\\xa0months. Ten participants completed follow-up between 3 to 5\\xa0months: eight in the intervention and two in the control group.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Outcomes']\n",
      "Para:  ['The primary outcome was change in HbA1c after 3-month follow-up. HbA1c was assessed centrally in an accredited laboratory, adhering to international criteria, set out according to International Organisation for Standardisation standards (ISO Standard 15,189:2012). HbA1c measurement was conducted using the turbidimetric inhibition immunoassay method, with a ROCHE COBAS intergra 400 plus analyser.Secondary outcomes were, changes in clinical, psychological, and self-care variables. Specifically, the clinical outcomes were change in weight, waist circumference, and blood pressure respectively; the psychological outcomes were changes in diabetes-related distress scores[15] and WHO quality of life scores respectively[16]; and the self-care outcome was change in diabetes self-care activities (SDSCA) scores [17].The SDSCA scale assesses the level of self-care in five domains, namely diet, exercise, glucose monitoring, foot care, and smoking. The WHO Qol Bref instrument assess the quality of life. We assessed diabetes-related distress with, the problem areas in diabetes-5 (PAID-5) scale. Increasing scores indicate increasing distress; scores of 8 or more suggest diabetes-related emotional distress [15].At follow-up, we assessed adverse events using a standardised questionnaire.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Statistical analysis']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Comparative analysis']\n",
      "Para:  ['Baseline sociodemographic, clinical, psychosocial, and self-care variables were summarised using median (interquartile range [IQR]) for continuous variables and counts (percentages) for categorical variables. All analysis was by intention to treat.The study was powered to detect the average response to the intervention, between the two groups. We therefore fitted a model to determine the difference in HbA1c at the end of the study. Specifically, we used linear mixed models to assess the intervention effect for the primary outcome. The models were adjusted for key prognostic factors, site, treatment arm, and follow-up duration. The model was parameterised as follows:where \\\\({Y}_{ij}\\\\) represents the outcome for subject \\\\(i\\\\) measured at ooccasion \\\\(j=\\\\mathrm{1,2}\\\\), \\\\({X}_{kij}\\\\) is the kth explanatory variable including an indicator for the intervention, \\\\({T}_{ij}\\\\) is the time variable, \\\\({\\\\beta }_{k+1}\\\\) are the fixed-effects,\\\\({b}_{0i}\\\\sim N\\\\left(0,{\\\\sigma }_{b}^{2}\\\\right)\\\\) is the random-effect accounting for within-subject correlation and \\\\({\\\\epsilon }_{ij}\\\\sim N(0, {\\\\sigma }^{2})\\\\) is the pure error term.All analysis was conducted in R statistical package and statistical significance was set at two-sided p\\u2009<\\u20090·05.The trial is registered on clinical trials.gov; registration number NCT04780425.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Results']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Baseline Characteristics']\n",
      "Para:  ['The baseline characteristics show high WHO Qol scores, despite low incomes, low literacy, and high unemployment levels (Table 1 /Supplementary Table 1). Furthermore, in most of the domains of the SDSCA score, the median score was once weekly. At baseline median HbA1c values were slightly higher in the intervention group than in the control group. (Table 1 and Supplementary Table 1). Notwithstanding sub-optimal baseline HbA1c values and low SDSCA scores, the overall median baseline PAID score was below eight.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Primary outcome']\n",
      "Para:  ['At endline, HbA1c decreased within both groups:-0·9% in the intervention group and -0·3% in the control group. Although this decrease was greater in the intervention group than in the control group, the difference between groups was not significant (Table 2). The primary outcome failed to reach significance. There was insufficient evidence that the intervention had an effect on HbA1c (Supplementary Figs.\\xa01 and 2).']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Secondary outcomes']\n",
      "Para:  ['Similarly, there was insufficient evidence that the intervention had an effect on any of the secondary outcomes except for an improvement in physical health. The difference in physical health between the intervention and control was 3 (p\\u2009=\\u20090.035)( Supplementary Table 4d). The within-group differences for both arms were also not significant for most clinical variables and psychological variables. The mean waist circumference of the control group was 1\\xa0cm higher relative to baseline (p\\u2009=\\u20090.015) while in the intervention arm, the mean waist circumference remained unchanged (p\\u2009=\\u20090.249). Similarly, the average systolic blood pressure increased by 5\\xa0mmHg (p\\u2009=\\u20090.143) in the control arm while in the intervention arm the mean systolic pressure remained unchanged (p\\u2009=\\u20090.249) ( Supplementary Tables 3c/3d). On the contrary, these differences were significant for self-care activities namely foot care, exercise, and diet. In the control arm, the mean number of days in a week, that participants inspected the inside of their shoes increased by 1\\xa0day at endline (p\\u2009=\\u20090.003). Correspondingly, among the intervention, the mean number of days per week increased by 2 (p\\u2009<\\u20090.001). ( Supplementary Tables 3a / 3b). The interaction term between the follow-up interval and intervention arm did not reach significance for any of the secondary outcomes.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Adverse events']\n",
      "Para:  ['No significant harms were observed. One participant however, had to be treated for symptomatic hypoglycaemia during delivery of the intervention. The participant’s medications included human insulin.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Discussion']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Conclusion']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Availability of data and materials']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Abbreviations']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['References']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Acknowledgements']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Funding']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Author information']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Authors and Affiliations']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Contributions']\n",
      "Para:  ['RL led in conceptualization of the study, drafting protocol, and data collection. RL wrote the first draft of the report with input from MAC, KKG, GOA, MMB, DD, and MH. MAC, KKG, RG, GOA, FA, MC, MH, MJD, IA, AY reviewed the protocol and submitted it for ethical clearance. DD participated in delivery of the intervention and data collection. RL prepared the analysis plan. Prior to seeing the data, MMB modified the analysis plan together with RL to increase the robustness of the analysis. SI then made additional modifications to the analysis plan together with RL. SI subsequently conducted the analysis. RL, GOA, SI, MAC, and KKG interpreted the analysis. All authors made corrections to the manuscript and approved the final document. All authors had full access to all the data in the study and have full responsibility for the decision to submit for publication. RL and DD have verified the data.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Corresponding author']\n",
      "Para:  ['Correspondence to\\n                Roberta Lamptey.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Ethics declarations']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Ethics approval and consent to participate']\n",
      "Para:  ['Ethical approval was provided by the Ghana Health Service Ethics Review Committee (protocol ID no: GHS-ERC 009/11/20), and the Institutional Review Board of KBTH (protocol ID no: KBTH-IRB 000175/2021). Prior to any study procedures, all participants gave written informed consent in person. The study was conducted in line with the principles of the Declaration of Helsinki.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Consent for publication']\n",
      "Para:  ['Consent for publication is not applicable.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Competing interests']\n",
      "Para:  ['\"The authors declare that they have no competing interests\".']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Additional information']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  [\"Publisher's Note\"]\n",
      "Para:  ['Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Supplementary Information']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Additional file 1.']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Additional\\xa0file 2.']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Additional\\xa0file 3.']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Rights and permissions']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['About this article']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Cite this article']\n",
      "Para:  ['Lamptey, R., Amoakoh-Coleman, M., Barker, M.M. et al. Change in glycaemic control with structured diabetes self-management education in urban low-resource settings: multicentre randomised trial of effectiveness.\\n                    BMC Health Serv Res 23, 199 (2023). https://doi.org/10.1186/s12913-023-09188-yDownload citation']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Share this article']\n",
      "Para:  ['Anyone you share the following link with will be able to read this content:\\n                            Provided by the Springer Nature SharedIt content-sharing initiative\\n                        ']\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Keywords']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n",
      "Header:  ['Follow BMC']\n",
      "Para:  []\n",
      "__________________________________\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import io\n",
    "data=[]\n",
    "\n",
    "for header in soup.find_all(['h1', 'h2', 'h3']):\n",
    "    h=[]\n",
    "    p=[]\n",
    "    h.append(header.get_text())\n",
    "    #print(\"Header: \", h)\n",
    "    for elem in header.next_siblings:\n",
    "        if elem.name and elem.name.startswith('h'):\n",
    "            # stop at next header\n",
    "            break\n",
    "        if elem.name == 'p':\n",
    "            p.append(elem.get_text())\n",
    "            if(len(p)>1):\n",
    "                para_string = ''.join(p)\n",
    "                p=[]\n",
    "                p.append(para_string)\n",
    "            \n",
    "    \n",
    "    print(\"Header: \", h)\n",
    "    print(\"Para: \", p)\n",
    "    print('__________________________________\\n')\n",
    "    d = h+p\n",
    "    if(len(d)==2):\n",
    "        data.append(d)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "3d4d9ee2",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "cols=['Header', 'Paragraph']\n",
    "df = pd.DataFrame(data, columns=cols)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "7a2d1627",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('data.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "02ae2136",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Header</th>\n",
       "      <th>Paragraph</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Change in glycaemic control with structured di...</td>\n",
       "      <td>\\nBMC Health Services Research\\nvolume 23, Art...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Background</td>\n",
       "      <td>In high-resource settings, structured diabetes...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Aim</td>\n",
       "      <td>To compare, structured diabetes self-managemen...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Design</td>\n",
       "      <td>Single-blind randomised parallel comparator co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Results</td>\n",
       "      <td>Recruitment: 22nd until 29th January 2021.We r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Conclusion</td>\n",
       "      <td>In low-resource settings, diabetes self-manage...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Study design and approval</td>\n",
       "      <td>A multicentre, parallel-group, single-blind ra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Ethical approval</td>\n",
       "      <td>Ethical approval was provided by the Ghana Hea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Study participants and study setting</td>\n",
       "      <td>Eligibility criteria included aged 18 years or...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Randomisation and masking</td>\n",
       "      <td>Participants were randomly assigned either to ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Follow-up intervals and assessments</td>\n",
       "      <td>The first 206 patients were consecutively rand...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Outcomes</td>\n",
       "      <td>The primary outcome was change in HbA1c after ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Comparative analysis</td>\n",
       "      <td>Baseline sociodemographic, clinical, psychosoc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Baseline Characteristics</td>\n",
       "      <td>The baseline characteristics show high WHO Qol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Primary outcome</td>\n",
       "      <td>At endline, HbA1c decreased within both groups...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Secondary outcomes</td>\n",
       "      <td>Similarly, there was insufficient evidence tha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Adverse events</td>\n",
       "      <td>No significant harms were observed. One partic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Contributions</td>\n",
       "      <td>RL led in conceptualization of the study, draf...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Corresponding author</td>\n",
       "      <td>Correspondence to\\n                Roberta Lam...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Ethics approval and consent to participate</td>\n",
       "      <td>Ethical approval was provided by the Ghana Hea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Consent for publication</td>\n",
       "      <td>Consent for publication is not applicable.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Competing interests</td>\n",
       "      <td>\"The authors declare that they have no competi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Publisher's Note</td>\n",
       "      <td>Springer Nature remains neutral with regard to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Cite this article</td>\n",
       "      <td>Lamptey, R., Amoakoh-Coleman, M., Barker, M.M....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Share this article</td>\n",
       "      <td>Anyone you share the following link with will ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               Header  \\\n",
       "0   Change in glycaemic control with structured di...   \n",
       "1                                          Background   \n",
       "2                                                 Aim   \n",
       "3                                              Design   \n",
       "4                                             Results   \n",
       "5                                          Conclusion   \n",
       "6                           Study design and approval   \n",
       "7                                    Ethical approval   \n",
       "8                Study participants and study setting   \n",
       "9                           Randomisation and masking   \n",
       "10                Follow-up intervals and assessments   \n",
       "11                                           Outcomes   \n",
       "12                               Comparative analysis   \n",
       "13                           Baseline Characteristics   \n",
       "14                                    Primary outcome   \n",
       "15                                 Secondary outcomes   \n",
       "16                                     Adverse events   \n",
       "17                                      Contributions   \n",
       "18                               Corresponding author   \n",
       "19         Ethics approval and consent to participate   \n",
       "20                            Consent for publication   \n",
       "21                                Competing interests   \n",
       "22                                   Publisher's Note   \n",
       "23                                  Cite this article   \n",
       "24                                 Share this article   \n",
       "\n",
       "                                            Paragraph  \n",
       "0   \\nBMC Health Services Research\\nvolume 23, Art...  \n",
       "1   In high-resource settings, structured diabetes...  \n",
       "2   To compare, structured diabetes self-managemen...  \n",
       "3   Single-blind randomised parallel comparator co...  \n",
       "4   Recruitment: 22nd until 29th January 2021.We r...  \n",
       "5   In low-resource settings, diabetes self-manage...  \n",
       "6   A multicentre, parallel-group, single-blind ra...  \n",
       "7   Ethical approval was provided by the Ghana Hea...  \n",
       "8   Eligibility criteria included aged 18 years or...  \n",
       "9   Participants were randomly assigned either to ...  \n",
       "10  The first 206 patients were consecutively rand...  \n",
       "11  The primary outcome was change in HbA1c after ...  \n",
       "12  Baseline sociodemographic, clinical, psychosoc...  \n",
       "13  The baseline characteristics show high WHO Qol...  \n",
       "14  At endline, HbA1c decreased within both groups...  \n",
       "15  Similarly, there was insufficient evidence tha...  \n",
       "16  No significant harms were observed. One partic...  \n",
       "17  RL led in conceptualization of the study, draf...  \n",
       "18  Correspondence to\\n                Roberta Lam...  \n",
       "19  Ethical approval was provided by the Ghana Hea...  \n",
       "20         Consent for publication is not applicable.  \n",
       "21  \"The authors declare that they have no competi...  \n",
       "22  Springer Nature remains neutral with regard to...  \n",
       "23  Lamptey, R., Amoakoh-Coleman, M., Barker, M.M....  \n",
       "24  Anyone you share the following link with will ...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "f6467dfb",
   "metadata": {},
   "outputs": [],
   "source": [
    "resolvedURLs=[]\n",
    "for item in soup.find_all('img'):\n",
    "    src = item.get('src')\n",
    "    resolvedURLs.append(requests.compat.urljoin(url1, src))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
